Safety

Cagrilintide

Adverse-event report summary for Cagrilintide, drawn from the FDA Adverse Event Reporting System (FAERS).

Total reports
4
Reports flagged serious
3

“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.

Most frequently reported reactions

  1. Dyspnoea2 reports
  2. Anal Incontinence1 reports
  3. Body Mass Index Decreased1 reports
  4. Decreased Appetite1 reports
  5. Gastroenteritis1 reports
  6. Illness1 reports
  7. Loss Of Consciousness1 reports
  8. Nausea1 reports
  9. Product Information Content Complaint1 reports
  10. Pruritus1 reports
  11. Throat Tightness1 reports
  12. Thyroid Mass1 reports
  13. Urticaria1 reports
  14. Vomiting1 reports
  15. Weight Decreased1 reports

Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.